Physio-Control nets monitor/defibrillator approval in Canada
Physio-Control, a wholly-owned subsidiary of Medtronic, has received approval by Health Canada to market the Lifepak 15 monitor/defibrillator within Canada.

The Redmond, Wash.-based Physio-Control was granted the CE Mark in January, certifying compliance with the European Union Medical Device Directive, and began its U.S. market release of the Lifepak 15 monitor/defibrillator in March.

The Lifepak 15 provides energy dosing up to 360 joules, and has various monitoring options available. The company also said its monitor/defibrillator integrates Masimo Rainbow Set Pulse CO-Oximetry technology for the noninvasive detection of carboxyhemoglobin (carbon monoxide in the blood) and methemoglobin in the blood (which may result from exposure to certain chemicals and drugs).